| 产品名称： |
(|S|)-4-(4-氨基苄基)-1，3-噁唑烷-2-酮,98% |
| 中文别名： |
(s)-4-(4-氨基苄基)-1,3-噁唑烷-2-酮;(S)-4-(4-氨基苄基)-1,3-噁唑-2-酮;(S)-4-(4-氨基苄基)-2-噁唑烷酮;(s)-4-(4-氨基苄基)-1,3-唑烷-2-酮;(S)-4-(4-Aminobenzyl)-2-oxazolidinone (S)-4-(4-氨基苄基)-2-噁唑烷酮;(S)-4-(4-氨基苄基)-1,3-?唑-2-;(s)-4-(4-氨基苄基)-1,3-?唑烷-2;(S)-4-(4-氨基苄基)-2-(1H)-恶唑烷酮;佐米曲普坦相关化合物G USP标准品;佐米曲普坦中间体;佐米曲普坦中间体（氨基物）;(4S)-4-[(4-氨基苯基)甲基]-2-恶唑烷酮;(s)-4-(4-氨基苄基)-1,3-噁唑烷-2-酮(佐米曲普坦中间体);(S)-4-(4-氨基苄基)-1,3-唑-2-酮;)-4-(4-氨基苄基)-1,3-噁唑烷-2-酮;佐米曲普坦;S-4-(4-氨基苄基)-1,3-噁唑烷酮;(S)-4-(4-氨基苄基)-1,3-恶唑烷酮;S)-4-(4-氨基苄基)-1,3-恶唑烷-2-酮;(S)-4-(4-氨基苄基)-1,3-恶唑烷-2-酮;(S)-4-(4-氨基苄基)-1,3-噁唑烷-2-酮,98%;(S)-4-(4-氨基苄基)-1,3-噁唑烷-2-酮;(S)-4-(4-氨基苄基)-1,3-唑烷-2-酮 |
| 英文名称： |
(|S|)-4-(4-Aminobenzyl)-2(1|H|)-oxazolidinone |
| 英文别名： |
(S)-4-(4-Aminobenzyl)oxazolidin-2-one;4-Hydrazinophenyl-N-methylmethane Sulfonamide;(S)-4-(4-Aminobenzyl)-2-oxazolidinone;4-(1H-1,2,4-triazol-yl-methyl)-benzene amine;(S)-4-(4-Aminobenzyl)-2(1H)-Oxazolidinone;(S)-4-(4-AMINOBENZYL)-1,3-OXAZOLIDIN-2-ONE;(S)-4-(4-Aminobenzyl)-2-(1H)-oxazolidinone;Zolmitriptan Intermediate Ⅰ;ZTR 5;(4S)-4-[(4-Aminophenyl)methyl]-2-oxazolidinone;Zolmitriptan USP RC G;ZolMitriptan IMpurity A;Zolmitriptan Related Compound G;(S)-4-(4'-AMINOBENZYL)-2-OXAZOLIDINONE;(S)-4-(4-AMINO-BENZYL)-OXAZOLIDIN-2-ONE;(S)-4-(4-AMINO-BENZYL)-OXAZOLIDINE-2-ONE;(S)-4-(4-AMINOBENZYL)-2(1H)-OXAZOLIDINO&;2-OXAZOLIDINONE, 4-[(4-AMINOPHENYL)METHYL]-, (4S)-;(S)-4-(4-Aminobenzyl)-1,3-oxozolidin-2-one;(4S)-4-[(4-aminophenyl)methyl]-1,3-oxazolidin-2-one;(s)-4-(4-aminobenzyl)-oxazolidine-2-one;s-4-(4-aminobenzyl)-1,3-oxazolidin-2-one;(4S)-4-[(4-aminophenyl)methyl]oxaz;(S)-4-(4-AMINOBENZYL)-2-OXAZOLIDINONE;(S)-4-(4-AMINOBENZYL)-2(1H)-OXAZOLIDINONE;(S)-4-(4-aminobenzyl)oxazolidin-2-one;(S)-4-(4'-AMINOBENZYL)-1,3-OXAZOLIDIN-2-ONE;(4S)-4-[(4-aminophenyl)methyl]oxazolidin-2-one;J-502456;BJO4G2UWA4;AM20060519;AKOS015889599;2-Oxazolidinone, 4-((4-aminophenyl)methyl)-, (4S)-;(4S)-4-Aminophenylmethyl-oxazolidine-2-one;340041-89-6;4-(4-Aminobenzyl)oxazolidin-2-one,(S)-;CS-W003042;(s)-4-(4-aminobenzyl)-2-(1h)-oxazolidinone;DS-11087;AKOS015855677;AMINOBENZYL OXAZOLIDINONE [USP IMPURITY];WNAVSKJKDPLWBD-VIFPVBQESA-N;SCHEMBL825617;(S)-4-(4-Aminobenzyl)-2(1H)-oxazolidinone;(4s)-(4-aminobenzyl)-2-oxazolidine-2-one;(4S)-4-((4-Aminophenyl)methyl)-1,3-oxazolidin-2-one;DTXSID301285890;ZOLMITRIPTAN IMPURITY E [EP IMPURITY];152305-23-2;Zolmitriptan impurity E [EP];(4S)-4-(4-Aminobenzyl)-1,3-oxazolidin-2-one;MFCD03411476;(S)-4-(4-Aminobenzyl)-2(1H)-oxazolidinone, 97%;(s)-4-(4-aminobenzyl)-1,3-oxazolidin 2-one;(s)-4-(4-aminobenzyl)-2-oxazolidinon;Aminobenzyl oxazolidinone [USP];(4S)-4-(4-amino-benzyl)-1,3-oxazolidin-2-one;UNII-BJO4G2UWA4;(4S)-4-((4-Aminophenyl)methyl)-2-oxazolidinone |
| 品牌： |
PERFEMIKER |
| CAS号： |
152305-23-2 |
| 分子式： |
C10H12N2O2 |
| 分子量： |
192.21 |
| 纯度： |
98% |
| 详细描述： |
博飞美科的(|S|)-4-(4-氨基苄基)-1，3-噁唑烷-2-酮,98%为恶唑,产品稳定,定制速度快,极大地方便了广大科研客户的使用需求。产品包装为1g。查询关键词:恶唑，152305-23-2，(|S|)-4-(4-氨基苄基)-1，3-噁唑烷-2-酮,98%，(|S|)-4-(4-Aminobenzyl)-2(1|H|)-oxazolidinone，博飞美科，Perfemiker，上海，厂家现货。 |
沪公网安备31011402010658号 
